HomeTrialNCT05618379
🔬NCT05618379ACTIVE NOT RECRUITING

Adult Spinal Muscular Atrophy (SMA) China Registry

Study Summary

The primary objective of the study is to describe the natural history and utilization of disease modifying therapy (DMT) among adult Chinese participants with SMA linked to chromosome 5q (5q-SMA).

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment200 participants
Primary Completion
Lead SponsorBiogen
Data Retrieved2026-04-11 02:55:21.687227+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.